CR
The startup develops medications and therapies through rigorous clinical trials to evaluate new treatment options for various medical conditions. By focusing on the systematic testing of breakthrough drugs, the company aims to enhance patient outcomes and expand the available therapeutic options in the healthcare market.
Updated 3 months ago
Funding
$3.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops medications and therapies through rigorous clinical trials to evaluate new treatment options for various medical conditions. By focusing on the systematic testing of breakthrough drugs, the company aims to enhance patient outcomes and expand the available therapeutic options in the healthcare market.